BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9465081)

  • 1. Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge.
    Belyakov IM; Derby MA; Ahlers JD; Kelsall BL; Earl P; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1998 Feb; 95(4):1709-14. PubMed ID: 9465081
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.
    Belyakov IM; Wyatt LS; Ahlers JD; Earl P; Pendleton CD; Kelsall BL; Strober W; Moss B; Berzofsky JA
    J Virol; 1998 Oct; 72(10):8264-72. PubMed ID: 9733870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucosal vaccination overcomes the barrier to recombinant vaccinia immunization caused by preexisting poxvirus immunity.
    Belyakov IM; Moss B; Strober W; Berzofsky JA
    Proc Natl Acad Sci U S A; 1999 Apr; 96(8):4512-7. PubMed ID: 10200293
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M cell DNA vaccination for CTL immunity to HIV.
    Wang X; Hone DM; Haddad A; Shata MT; Pascual DW
    J Immunol; 2003 Nov; 171(9):4717-25. PubMed ID: 14568947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral DNA vaccination promotes mucosal and systemic immune responses to HIV envelope glycoprotein.
    Kaneko H; Bednarek I; Wierzbicki A; Kiszka I; Dmochowski M; Wasik TJ; Kaneko Y; Kozbor D
    Virology; 2000 Feb; 267(1):8-16. PubMed ID: 10648178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interplay of cytokines and adjuvants in the regulation of mucosal and systemic HIV-specific CTL.
    Belyakov IM; Ahlers JD; Clements JD; Strober W; Berzofsky JA
    J Immunol; 2000 Dec; 165(11):6454-62. PubMed ID: 11086085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal and vaginal immunization with a macromolecular multicomponent peptide vaccine candidate for HIV-1 infection induces HIV-specific protective immune responses.
    Kato H; Bukawa H; Hagiwara E; Xin KQ; Hamajima K; Kawamoto S; Sugiyama M; Sugiyama M; Noda E; Nishizaki M; Okuda K
    Vaccine; 2000 Jan; 18(13):1151-60. PubMed ID: 10649615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brucella abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice.
    Lapham C; Golding B; Inman J; Blackburn R; Manischewitz J; Highet P; Golding H
    J Virol; 1996 May; 70(5):3084-92. PubMed ID: 8627787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Helper-cytotoxic T lymphocyte (CTL) determinant linkage required for priming of anti-HIV CD8+ CTL in vivo with peptide vaccine constructs.
    Shirai M; Pendleton CD; Ahlers J; Takeshita T; Newman M; Berzofsky JA
    J Immunol; 1994 Jan; 152(2):549-56. PubMed ID: 8283036
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous approach using systemic, mucosal and transcutaneous routes of immunization for development of protective HIV-1 vaccines.
    Belyakov IM; Ahlers JD
    Curr Med Chem; 2011; 18(26):3953-62. PubMed ID: 21824096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of local mucosal HIV-specific CD8(+) cytotoxic T lymphocytes for resistance to mucosal viral transmission in mice and enhancement of resistance by local administration of IL-12.
    Belyakov IM; Ahlers JD; Brandwein BY; Earl P; Kelsall BL; Moss B; Strober W; Berzofsky JA
    J Clin Invest; 1998 Dec; 102(12):2072-81. PubMed ID: 9854042
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel functional CTL avidity/activity compartmentalization to the site of mucosal immunization contributes to protection of macaques against simian/human immunodeficiency viral depletion of mucosal CD4+ T cells.
    Belyakov IM; Isakov D; Zhu Q; Dzutsev A; Berzofsky JA
    J Immunol; 2007 Jun; 178(11):7211-21. PubMed ID: 17513770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of novel type I interferon epsilon in viral infection and mucosal immunity.
    Xi Y; Day SL; Jackson RJ; Ranasinghe C
    Mucosal Immunol; 2012 Nov; 5(6):610-22. PubMed ID: 22617838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Candidate HIV type 1 multideterminant cluster peptide-P18MN vaccine constructs elicit type 1 helper T cells, cytotoxic T cells, and neutralizing antibody, all using the same adjuvant immunization.
    Ahlers JD; Dunlop N; Pendleton CD; Newman M; Nara PL; Berzofsky JA
    AIDS Res Hum Retroviruses; 1996 Mar; 12(4):259-72. PubMed ID: 8906986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An experimental prime-boost regimen leading to HIV type 1-specific mucosal and systemic immunity in BALB/c mice.
    Brühl P; Kerschbaum A; Eibl MM; Mannhalter JW
    AIDS Res Hum Retroviruses; 1998 Mar; 14(5):401-7. PubMed ID: 9546799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization with Th-CTL fusion peptide and cytosine-phosphate-guanine DNA in transgenic HLA-A2 mice induces recognition of HIV-infected T cells and clears vaccinia virus challenge.
    Daftarian P; Ali S; Sharan R; Lacey SF; La Rosa C; Longmate J; Buck C; Siliciano RF; Diamond DJ
    J Immunol; 2003 Oct; 171(8):4028-39. PubMed ID: 14530323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The induction of HIV Gag-specific CD8+ T cells in the spleen and gut-associated lymphoid tissue by parenteral or mucosal immunization with recombinant Listeria monocytogenes HIV Gag.
    Peters C; Peng X; Douven D; Pan ZK; Paterson Y
    J Immunol; 2003 May; 170(10):5176-87. PubMed ID: 12734365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal and systemic immune responses to a human immunodeficiency virus type 1 epitope induced upon vaginal infection with a recombinant influenza A virus.
    Garulli B; Kawaoka Y; Castrucci MR
    J Virol; 2004 Jan; 78(2):1020-5. PubMed ID: 14694134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic immunity and mucosal immunity are induced against human immunodeficiency virus Gag protein in mice by a new hyperattenuated strain of Listeria monocytogenes.
    Rayevskaya MV; Frankel FR
    J Virol; 2001 Mar; 75(6):2786-91. PubMed ID: 11222702
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral Immunization with a Recombinant Lactococcus lactis-Expressing HIV-1 Antigen on Group A Streptococcus Pilus Induces Strong Mucosal Immunity in the Gut.
    Chamcha V; Jones A; Quigley BR; Scott JR; Amara RR
    J Immunol; 2015 Nov; 195(10):5025-34. PubMed ID: 26482408
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.